About the Authors
- Cyrille Touzeau
-
Roles Validation, Writing – review & editing
* E-mail: Cyrille.Touzeau@chu-nantes.fr
Affiliation Centre Hospitalier Universitaire de Nantes, Nantes, France
- Fanny Raguideau
-
Roles Conceptualization, Methodology, Writing – original draft
Affiliation HEVA, Lyon, France
- Hélène Denis
-
Roles Methodology, Project administration, Writing – review & editing
Affiliation HEVA, Lyon, France
- Ludovic Lamarsalle
-
Roles Conceptualization, Methodology, Supervision
Affiliation HEVA, Lyon, France
- Caroline Guilmet
-
Roles Conceptualization, Writing – review & editing
Affiliation Janssen-cilag France, Issy-les-Moulineaux, France
- Matthieu Javelot
-
Roles Conceptualization, Supervision, Writing – review & editing
Affiliation Janssen-cilag France, Issy-les-Moulineaux, France
- Marie Pierres
-
Roles Conceptualization, Project administration, Supervision, Writing – review & editing
Affiliation Janssen-cilag France, Issy-les-Moulineaux, France
- Aurore Perrot
-
Roles Validation, Writing – review & editing
Affiliation Institut Universitaire du Cancer Toulouse – Oncopole, Toulouse, France
Competing Interests
I have read the journal's policy and the authors of this manuscript have the following competing interests: CT/AP: JANSSEN, Amgen, BMS/Celgene, GSK, Takeda and Sanofi. MJ are MP are employees of Janssen Cilag France. CG was also an employee of Janssen Cilag France at the time this study was conducted. FR, LL, HD are employees of HEVA, who received financial compensation from JANSSEN Cilag France to conduct the study. his does not alter our adherence to PLOS ONE policies on sharing data and materials.